Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · Real-Time Price · USD

27.11

+0.04 (0.15%)

At close: Aug 4, 2026, 4:00 PM EDT

27.89

+0.78 (2.89%)

After-hours: Aug 4, 2026, 4:26 PM EDT

Alamar Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	74.21	74.21	25.14
Revenue Growth	-	195.17%	-
Gross Profit	41.71	41.71	8.61
Operating Income	-31.33	-31.33	-49.57
Net Income	-29.82	-29.82	-46.27
Earnings Per Share	-2.58	-2.58	-4.60
EPS Growth	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
United States	50.85	45.42	14.55
Asia-Pacific	7.78	5.82	0.49
Europe, Middle East and Africa (Excluding Germany)	-	14.12	5.65
Germany	-	8.31	4.42
Rest of The World	-	0.54	0.03
Total	87.16	74.21	25.14

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	64.59	30	79.36
Total Debt	105.55	41.47	33.1
Net Cash (Debt)	-40.96	-11.47	46.26
Net Cash Growth	-	-	-
Net Cash Per Share	-3.18	-0.99	3.89

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-53.61	-53.61	-55.21
Capital Expenditures	-5.37	-5.37	-2.95
Free Cash Flow	-58.98	-58.98	-58.16
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	56.20%	56.20%	34.23%
Operating Margin	-42.22%	-42.22%	-197.15%
Pretax Margin	-39.29%	-39.29%	-187.18%
Profit Margin	-40.18%	-40.18%	-187.23%
FCF Margin	-79.48%	-79.48%	-231.33%